LEXINGTON, Mass. - Agenus Inc . (NASDAQ:AGEN), an immuno-oncology company with a market capitalization of $85 million, revealed study results published in the Journal of Clinical Oncology that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback